2012 Press Releases

    Print Page  Close Window
Keyword Search
 
2014 | 2013 | 2012 | 2011 | 2010
DateTitle 
12/14/12BioMed Realty Trust Declares Fourth Quarter 2012 Common Stock And Preferred Stock Dividends
Increases common stock dividend by 9.3% SAN DIEGO, Dec. 14, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a fourth quarter 2012 dividend of $0.235 per share of common stock, representing a 9.3% increase over the company's third quarter 2012 dividend of $0.215 per share.  The dividend is equivalent to an annualized dividend of $0.94 per common share. BioMed Realty also announced that its board of direct... 
Printer Friendly Version
11/09/12BioMed Realty To Audio Webcast Company Presentation At Investor Day 2012
SAN DIEGO, Calif., Nov. 9, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) will audio webcast the company's presentation at its Investor Day 2012 to be held on Monday, November 12, 2012 at the Marriott Marquis in San Diego. The audio webcast will feature presentations by members of BioMed Realty's senior management team. The live audio webcast will be broadcast through a link on BioMed Realty's website, www.biomedrealty.com, from approximately 4:00 p.m. to 5:15 p.m. Pacific Time... 
Printer Friendly Version
11/01/12BioMed Realty Trust Reports Third Quarter 2012 Financial Results
Year-over-year FFO and AFFO per share rise 13.3% and 10.0%, respectively SAN DIEGO, Nov. 1, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR), a real estate investment trust (REIT) that delivers optimal real estate solutions for the life science industry, today announced financial results for the third quarter ended September 30, 2012. Third Quarter 2012 Highlights Increased funds from operations (FFO) for the quarter by 13.3% to $0.34 per diluted share, as co... 
Printer Friendly Version
10/31/12BioMed Realty Announces 93,000 Square Foot Lease Expansion And Extension With Ironwood Pharmaceuticals At 301 Binney Street
SAN DIEGO, Oct. 31, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the signing of an amendment to the lease with Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) at its 301 Binney Street facility in Cambridge, Massachusetts.  As a result of this lease extension and phased expansion totaling approximately 93,000 square feet, Ironwood's occupancy in the five-story, state-of-the-art facility will increase to approximately 303,000 square feet. The term of the ... 
Printer Friendly Version
10/26/12BioMed Realty Announces 80,500 Square Foot Lease Expansion For Regeneron Pharmaceuticals
SAN DIEGO, Oct. 26, 2012 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) today announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has leased an additional 80,500 square feet of space at The Landmark at Eastview campus in Tarrytown, New York comprised of approximately 46,000 square feet of space in the 777 Building and approximately 34,500 square feet of space in the 765 Building. Named as the world's top biopharmaceutical employer in a recent Science magazine survey... 
Printer Friendly Version
10/22/12BioMed Realty Trust To Report 2012 Third Quarter Results
SAN DIEGO, Oct. 22, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its third quarter ended September 30, 2012 after the market closes on Thursday, November 1, 2012. Alan D. Gold, Chairman and Chief Executive Officer, Kent Griffin, President, Matt McDevitt, Executive Vice President, and Greg N. Lubushkin, Chief Financial Officer, will host an investor conference call at 10:00 a.m. Pacific Time on Friday, November 2, 2012 to discuss the ... 
Printer Friendly Version
09/14/12BioMed Realty Trust Declares Third Quarter 2012 Common Stock And Preferred Stock Dividends
SAN DIEGO, Sept. 14, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a third quarter 2012 dividend of $0.215 per share of common stock.  The dividend is equivalent to an annualized dividend of $0.86 per common share. BioMed Realty also announced that its board of directors has declared a dividend of $0.46094 per share of the company's 7.375% Series A Cumulative Redeemable Preferred Stock for the period from July 16, 2012 t... 
Printer Friendly Version
08/21/12Senior Leaders At BioMed Realty Recognized
Karen Sztraicher Promoted to Executive Vice President, Asset Management; Jonathan Klassen Promoted to General Counsel SAN DIEGO, Aug. 21, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the promotion of Karen A. Sztraicher to Executive Vice President, Asset Management and Jonathan P. Klassen to Senior Vice President and General Counsel. Alan D. Gold, Chairman and Chief Executive Officer of BioMed Realty, remarked, "I am very pleased to announce the... 
Printer Friendly Version
08/08/12BioMed Realty Announces New Brand Identity
SAN DIEGO, Aug. 8, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today unveiled a new brand identity that highlights the company's commitment to the life science industry by delivering state-of-the-art laboratories and office spaces to meet the unique needs of its tenants. The brand identity features an energetic new look comprised of a monogram logo in the stylized shape of the company's initials and NYSE ticker symbol, BMR, and a new tagline, Discover here™. "Bio... 
Printer Friendly Version
08/02/12BioMed Realty Trust Converts $156.4 Million Of Its Senior Unsecured Term Loan To 100 Million Pounds Sterling
SAN DIEGO, Aug. 2, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that the company has closed on an amendment to its senior unsecured term loan facility which converts $156.4 million of the $400 million principal amount outstanding to 100 million pounds sterling and provides for the base rate index on this portion of the facility to be GBP 1-month LIBOR. All other material terms and conditions of the term loan facility remain unchanged, including the interest rate m... 
Printer Friendly Version
08/01/12BioMed Realty Trust Reports Second Quarter 2012 Financial Results
Core FFO per share climbs 10.3% year-over-year to $0.32 per diluted share SAN DIEGO, Aug. 1, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR), a real estate investment trust focused on Providing Real Estate to the Life Science Industry®, today announced financial results for the second quarter ended June 30, 2012. Second Quarter 2012 Highlights Increased core funds from operations (CFFO) per share for the quarter by 10.3% to $0.32 per diluted share, as comp... 
Printer Friendly Version
07/24/12BioMed Realty Trust To Report 2012 Second Quarter Results
SAN DIEGO, July 24, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its second quarter ended June 30, 2012 after the market closes on Wednesday, August 1, 2012. Alan D. Gold, Chairman and Chief Executive Officer, Kent Griffin, President, Matt McDevitt, Executive Vice President, and Greg N. Lubushkin, Chief Financial Officer, will host an investor conference call at 9:00 a.m. Pacific Time on Thursday, August 2, 2012 to discuss the compan... 
Printer Friendly Version
07/16/1281,200 Square Foot Lease Extension In San Diego Through 2018 Signed By Vertex Pharmaceuticals And BioMed Realty
SAN DIEGO, July 16, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today the signing of a lease extension with Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) for approximately 81,200 square feet at the company's Torreyana Road property located in the heart of the Torrey Pines submarket of San Diego, California. The lease now extends through December 31, 2018. Ranked as the top place to work in the life science industry by Science magazine in 2011, Vertex has recei... 
Printer Friendly Version
06/28/12BioMed Realty, L.P. Announces Closing Of Offering Of 4.25% Senior Unsecured Notes Due 2022
SAN DIEGO, June 28, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its operating partnership subsidiary, BioMed Realty, L.P., completed a public offering of $250 million aggregate principal amount of 4.25% Senior Notes due 2022 (the "Notes").  The Notes are senior unsecured obligations of the operating partnership and are fully and unconditionally guaranteed by BioMed Realty Trust, Inc.  Interest on the Notes is payable semiannually on January 15 and July 1... 
Printer Friendly Version
06/21/12BioMed Realty, L.P. Prices $250 Million Offering Of 4.25% Senior Unsecured Notes Due 2022
SAN DIEGO, June 21, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR)  today announced that its operating partnership subsidiary, BioMed Realty, L.P., priced a public offering of $250 million aggregate principal amount of 4.25% Senior Notes due 2022 (the "Notes").  The Notes were priced at 99.126% of the principal amount to yield 4.358% to maturity.  The Notes will be senior unsecured obligations of the operating partnership and will be fully and unconditionally guaranteed by BioMed R... 
Printer Friendly Version
06/15/12BioMed Realty Trust Declares Second Quarter 2012 Common Stock And Preferred Stock Dividends
SAN DIEGO, June 15, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a second quarter 2012 dividend of $0.215 per share of common stock.  The dividend is equivalent to an annualized dividend of $0.86 per common share. BioMed Realty also announced that its board of directors has declared a dividend of $0.46094 per share of the company's 7.375% Series A Cumulative Redeemable Preferred Stock for the period from April 16, 2012 ... 
Printer Friendly Version
06/11/12Biomed Realty To Acquire Granta Park In Cambridge, UK For 126.8 Million Pounds Sterling
Premier life science research park includes eleven buildings encompassing 472,200 square feet SAN DIEGO, June 11, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that it has entered into a definitive agreement to acquire Granta Park, comprising eleven laboratory and office buildings and a total of approximately 472,200 square feet of space, as well as approximately 138,400 square feet of development and expansion rights, in Cambridge, United Kingdom. The purchase pr... 
Printer Friendly Version
06/11/12BioMed Realty Trust to Present at REITWeek 2012
SAN DIEGO, June 11, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that members of its executive management will present at REITWeek 2012: NAREIT's Investor Forum® in New York City on Wednesday, June 13, 2011 at approximately 8:00 a.m. Eastern Daylight Time. A live webcast of the presentation will be available to all investors by accessing the company's website at www.biomedrealty.com. The complete webcast will be archived for 30 days. About BioMed Realty Tru... 
Printer Friendly Version
06/11/12BioMed Realty Partners With Advanced BioHealing, A Subsidiary Of Shire plc, To Develop Regenerative Medicine Campus In San Diego
SAN DIEGO, June 11, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that it has completed the acquisition of two parcels of land, comprising approximately 28 adjacent acres in San Diego, California for a purchase price of approximately $47 million, excluding transaction costs. Concurrently, the company has entered into a long-term ground lease for both sites with Advanced BioHealing, Inc. (ABH), a regenerative medicine company and a subsidiary of Shire plc, which dev... 
Printer Friendly Version
05/10/12New 126,000 Square Foot Lease at 650 East Kendall Street Signed By BioMed Realty
SAN DIEGO, Calif., May 10, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) and AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) today announced the signing of a new twelve-year lease for 126,000 square feet of laboratory and office space at 650 East Kendall Street, in the heart of the Kendall Square biotechnology super-cluster in Cambridge, Massachusetts. AVEO will move its headquarters and primary research facilities to the six-story, state-of-the-art multi-tenant research facility that i... 
Printer Friendly Version
05/01/12BioMed Realty Trust Reports First Quarter 2012 Financial Results
Strong Leasing Volume of 466,000 Square Feet; FFO guidance increased SAN DIEGO, May 1, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR), a real estate investment trust focused on Providing Real Estate to the Life Science Industry®, today announced financial results for the first quarter ended March 31, 2012. First Quarter 2012 Highlights Generated total revenues for the quarter of $120.0 million, up 14.1% from $105.2 million in the same period in 2011 and the highest in the ... 
Printer Friendly Version
04/24/12BioMed Realty Trust To Report 2012 First Quarter Results
SAN DIEGO, April 24, 2012 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its first quarter ended March 31, 2012 after the market closes on Tuesday, May 1, 2012. Alan D. Gold, Chairman and Chief Executive Officer, Kent Griffin, President, Matt McDevitt, Executive Vice President, and Greg N. Lubushkin, Chief Financial Officer, will host an investor conference call at 10:00 a.m. Pacific Time on Wednesday, May 2, 2012 to discuss the comp... 
Printer Friendly Version
04/16/12BioMed Realty Trust Introduces its 2011 Online Annual Report
SAN DIEGO, Calif., April 16, 2012 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) announced today that its 2011 Online Annual Report and other proxy materials are now available at http://www.biomedrealty.com/11AR. BioMed Realty is posting its annual report in an online format following the SEC-approved electronic reporting guidelines for the fourth consecutive year. The 2011 Online Annual Report, entitled "Creating Value," highlights the company's breakthrough operating and fi... 
Printer Friendly Version
04/09/12New 60,000 Square Foot Lease at the Pacific Research Center Signed by Biomed Realty and Depomed
SAN DIEGO, April 9, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today the signing of a new ten-year lease with Depomed, Inc. (NASDAQ: DEPO) at its Pacific Research Center campus in Newark, California. Depomed, a specialty pharmaceutical company, leased approximately 60,000 square feet of space at Pacific Research Center North on BioMed Realty's multi-tenant Pacific Research Center campus. Commenting on their relocation to the Pacific Research Center, Jim Schoeneck, ... 
Printer Friendly Version
04/03/12BioMed Realty Trust Completes $400 Million Senior Unsecured Term Loan Financing
SAN DIEGO, April 3, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that the company has closed a new $400 million senior unsecured term loan facility. The new facility matures on March 30, 2017. The interest rate paid on drawings under the new facility is currently set at LIBOR plus 1.65%, subject to adjustments based on BioMed's credit ratings.  The company used the proceeds from this new facility to repay a portion of the outstanding indebtedness under its unsecur... 
Printer Friendly Version
03/15/12Biomed Realty Trust Declares First Quarter 2012 Common Stock and Preferred Stock Dividends
Increases common stock dividend by 7.5% SAN DIEGO, March 15, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a first quarter 2012 dividend of $0.215 per share of common stock, representing a 7.5% increase over the company's fourth quarter 2011 dividend of $0.20 per share.  The dividend is equivalent to an annualized dividend of $0.86 per common share. BioMed also announced that its board of directors has dec... 
Printer Friendly Version
03/13/12BioMed Realty Trust to Present at Citi 2012 Global Property CEO Conference
SAN DIEGO, March 13, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that members of its executive management will present at the Citi 2012 Global Property CEO Conference in Palm Beach, Florida at approximately 10:10 a.m. Eastern Daylight Time on Wednesday, March 14, 2012.  The presentation will be open to all investors by calling 877-211-0500 (domestic) or 201-984-1145 (international) and providing the passcode 6043504. About BioMed Realty Trust ... 
Printer Friendly Version
03/07/12BioMed Realty Signs New Long Term 220,000 Square Foot Lease at the Pacific Research Center
SAN DIEGO, March 7, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today the signing of a new long term lease with a private biotech company for 220,000 square feet of space at BioMed Realty's multi-tenant Pacific Research Center campus in San Francisco's East Bay. Alan D. Gold, Chairman and Chief Executive Officer of BioMed Realty, said, "We welcome this new biotech company to the Pacific Research Center community, which will join nine other companies ... 
Printer Friendly Version
03/05/12BioMed Realty Trust to Present at the Raymond James 33rd Annual Institutional Investors Conference
SAN DIEGO, March 5, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that members of its executive management will present at the Raymond James 33rd Annual Institutional Investors Conference in Orlando, Florida at approximately 1:05 p.m. Eastern Standard Time on Tuesday, March 6, 2012.  A live webcast of the presentation will be available to all investors by accessing the company's website at www.biomedrealty.com. The complete webcast will be archived for 30 days.... 
Printer Friendly Version
02/08/12BioMed Realty Trust Reports Fourth Quarter and Full-Year 2011 Financial Results
Generates Five-Quarter Leasing Volume of 2,000,000 Square Feet; Total Assets and Total Revenues Up 12% and 14% Over 2010, Respectively SAN DIEGO, Feb. 8, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR), a real estate investment trust focused on Providing Real Estate to the Life Science Industry®, today announced financial results for the fourth quarter and full-year ended December 31, 2011. Fourth Quarter 2011 Highlights Generated total revenues for the quarter of $112.4 mi... 
Printer Friendly Version
02/06/12BioMed Realty Trust to Acquire Cambridge Place For $119 Million
Acquisition will expand total Boston/Cambridge, Massachusetts portfolio to approximately 3.2 million square feet SAN DIEGO, Feb. 6, 2012 - PRNewswire via COMTEX - BioMed Realty Trust, Inc. (NYSE: BMR) today announced that it has entered into a definitive agreement to acquire Cambridge Place, comprising three buildings and a total of approximately 287,000 square feet of space in Cambridge, Massachusetts. In aggregate, the property is approximately 80% leased, principally to CDM Smith, Inc.,... 
Printer Friendly Version
02/01/12BioMed Realty and Omeros Sign New 64,500 Square Foot Lease in Seattle
SAN DIEGO, Feb. 1, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today the signing of a new 15-year lease with Omeros Corporation (NASDAQ: OMER) for BioMed's Waterfront Research Center property located in Seattle, Washington.  A clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, coagulopathies and disorders of the central nervous system, Omeros will relocate and consolidate their corporate h... 
Printer Friendly Version
01/31/12BioMed Realty Trust to Report 2011 Fourth Quarter and Year End Results
SAN DIEGO, Jan. 31, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its fourth quarter and year ended December 31, 2011 after the market closes on Wednesday, February 8, 2012. Alan D. Gold, Chairman and Chief Executive Officer, Kent Griffin, President, Matt McDevitt, Executive Vice President, and Greg N. Lubushkin, Chief Financial Officer, will host an investor conference call at 10:00 a.m. Pacific Time on Thursday, February 9, 2012 t... 
Printer Friendly Version
01/17/12BioMed Realty Trust Announces Tax Treatment of 2011 Distributions
SAN DIEGO, Jan. 17, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE:BMR) today announced the tax treatment of its 2011 distributions as follows: Security Description: Common Stock CUSIP: 09063H107 Ticker Symbol: BMR   Record Date Payable Date Total Distribution Per Share Allocable to 2011 Taxable Ordinary Dividend   Return of Capital Long-Term Capital Gain Unrecaptured Section 1250 Gain 12/31/2... 
Printer Friendly Version